PRASOLCHEM
1 call
Concalls & earnings callsPrasol Chemicals Limited
Every summarised call, newest first. Latest is Q1 FY27, held 29 Sept 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Q1 FY27 was exceptionally strong on inventory gains from West Asia-led acetone price rises, while underlying mid-single-digit volume growth remained healthy and management guided for INR1,550 crores to INR1,650 crores revenue in FY27 with normalization of margins ahead.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue from operations - Q1 FY27 | ₹433.6 Cr | a growth of 35.7% YoY | |
| Gross margin - Q1 FY27 | 37.9% | compared to 30% in Q1 FY26 | |
| EBITDA - Q1 FY27 | ₹90.3 Cr | a growth of 122.4% YoY | |
| EBITDA margin - Q1 FY27 | 20.8% | against 12.7% in the same quarter last year |
Latest guidance
- For '27, expect to deliver a revenue of INR1,550 crores to INR1,650 crores with an EBITDA of INR240 crores to INR250 crores, excluding price fluctuation due to geopolitical-led supply chain issues and forex gain/losses, if any
- Aspire to scale the business to INR2,800 crores to INR3,000 crores in the next 5 years, supported by capacity expansions and higher value-added offerings
- See sustainable gross margins in the range of about 30%, 32% on a normalized basis
- End of year EBITDA margin in the range of 15% to 16%
- Phase 1 expansion of about 250 crores to 300 crores to be completed over the next two years, expected to generate about INR500 to INR550 crores of revenue at peak utilization
Said on the Q1 FY27 call.
Call history
- Q1 FY27Positive tone
Q1 FY27 was exceptionally strong on inventory gains from West Asia-led acetone price rises, while underlying mid-single-digit volume growth remained healthy and management guided for INR1,550 crores to INR1,650 crores revenue in FY27 with normalization of margins ahead.
- Revenue from operations - Q1 FY27
- ₹433.6 Cra growth of 35.7% YoY
- Gross margin - Q1 FY27
- 37.9%compared to 30% in Q1 FY26